ahlam1399
09-25-2015, 03:06 PM
**vo **rdisk successfully completes diabetes drug phase 3a trial
COPENHAGEN (Reuters) - Danish pharmaceutical company **vo **rdisk has successfully completed the second phase 3a trial with its diabetes drug semaglutide, it said on Friday.
http://rc.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/a2.img (http://da.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/ach.img (http://adchoice.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/ach.htm)http://pi.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/a2t.imghttp://pi2.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4a277b44/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=xZAUpeynhcA:cOFQdmnj1H8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=xZAUpeynhcA:cOFQdmnj1H8:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=xZAUpeynhcA:cOFQdmnj1H8:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=xZAUpeynhcA:cOFQdmnj1H8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=xZAUpeynhcA:cOFQdmnj1H8:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/xZAUpeynhcA
COPENHAGEN (Reuters) - Danish pharmaceutical company **vo **rdisk has successfully completed the second phase 3a trial with its diabetes drug semaglutide, it said on Friday.
http://rc.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/rc/1/rc.img (http://rc.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/rc/1/rc.htm)
http://rc.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/rc/2/rc.img (http://rc.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/rc/2/rc.htm)
http://rc.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/rc/3/rc.img (http://rc.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/a2.img (http://da.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/ach.img (http://adchoice.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/ach.htm)http://pi.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/a2t.imghttp://pi2.feedsportal.com/r/238386330865/u/49/f/654207/c/35217/s/4a277b44/sc/21/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4a277b44/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=xZAUpeynhcA:cOFQdmnj1H8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=xZAUpeynhcA:cOFQdmnj1H8:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=xZAUpeynhcA:cOFQdmnj1H8:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=xZAUpeynhcA:cOFQdmnj1H8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=xZAUpeynhcA:cOFQdmnj1H8:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/xZAUpeynhcA